opinionated-opinion

[opinionated-opinion]

The Role of Epigenetic Modifications in Gene Regulation: A Critical Review Cellular differentiation, development, and response to various environmental changes all are multistep biological processes that depend fundamentally on gene regulation. Epigenetic modifications allow the cell to respond interactively to environmental changes without altering the DNA sequence and have thus gained increased attention during the last few years. This blog will critically review some of the important epigenetic mechanisms-DNA methylation, histone modifications, and noncoding RNAs-and their involvement in health and disease.

What is Epigenetic? Epigenetics is defined as the study of heritable features concerning the role of gene regulation and not the underlying DNA sequence. These types of modification, usually reversible, have the ability to dynamically alter the expression of a gene by a cell. The epigenetic mechanisms allow cell differentiation in multicellular organisms beginning from the same DNA sequence genome.

Key Mechanisms of Epigenetic Regulation

DNA Methylation

DNA Methylation DNA methylation is one among the well-studied epigenetic mechanisms. It comprises the addition of a methyl group to the cytosine residue in the CpG dinucleotides, usually associated with the silencing of gene expression. Methylation patterns are important in normal development, while abnormal methylation is associated with diseases including cancer. For instance, the hypermethylation of tumor suppressor genes has been related to the inactivation of such genes in many kinds of cancers Esteller 2007.

Histone Modifications

DNA wraps around core histone proteins to form a nucleoprotein called chromatin, and changing the tail domains of the histones affects both the structure of chromatin and gene expression. Acetylation, methylation, phosphorylation, and sumoylation of histones affects the access of DNA to the transcriptional machinery. For example, in general, histone acetylation activates transcription whereas deacetylation causes silencing, Kouzarides 2007.

Non-coding RNAs: ncRNAs Non-coding RNAs, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), also play significant roles in gene regulation. miRNAs can degrade messenger RNA (mRNA) or inhibit translation, thus controlling gene expression post-transcriptionally. lncRNAs, on the other hand, regulate gene expression at various levels, including chromatin modification, transcription, and post-transcriptional processes (Rinn & Chang, 2012).

Critical Review: Epigenetic Changes Are of a Janus Nature Epigenetic modification is an indispensable component in physiological processes but turns out to be a double-edged sword since inappropriate epigenetic change gives rise to diseases like tumorigenesis, neurodegeneration, and autoimmune disease.

Epigenetic Therapies Epigenetic alterations, due to their reversible nature, represent very promising therapeutic targets. Therapeutic drugs like DNA methyltransferase inhibitors (for example, azacitidine) and histone deacetylase inhibitors (for example, vorinostat) are effective in the treatment of some cancers (Jones et al., 2016). However, the main challenges lie in guaranteeing specificity because broad epigenetic reprogramming leads to off-target effects.

Epigenetic and Environmental Influence The epigenome is very sensitive to nutrition, toxicants, and stresses. For example, prenatal exposure to malnutrition results in epigenetic modification, increasing the susceptibility to metabolic diseases later in life (Heijmans et al., 2008). Such sensitivities underline how understanding of epigenetic regulation involves lifestyle factors.

Conclusion:

Epigenetic modifications also play crucial roles in fine-tuning gene expression and the maintenance of cellular homeostasis. While allowing new possibilities of therapeutic intervention, especially in cancer, some problems remain to be investigated concerning specificity and also environmental impact. Further research will thus become necessary regarding the dynamic nature of the epigenome if specific and efficacious treatments are to be developed.

References

Esteller, M. (2007). Epigenetic gene silencing in cancer: The DNA hypermethylome. Human Molecular Genetics, 16(R1), R50–R59.

Heijmans, B. T., Tobi, E. W., Stein, A. D., Putter, H., Blauw, G. J., Susser, E. S., Slagboom, P. E., & Lumey, L. H. (2008). Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proceedings of the National Academy of Sciences, 105(44), 17046-17049.

Jones, P. A., Issa, J. P., & Baylin, S. (2016). Targeting the cancer epigenome for therapy. Nature Reviews Genetics, 17(10), 630–641.

Kouzarides, T. (2007). Chromatin modifications and their function. Cell, 128(4), 693-705.

Rinn, J. L., & Chang, H. Y. (2012). Genome regulation by long noncoding RNAs. Annual Review of Biochemistry, 81, 145-166.